心脏骤停后急性肾损伤的肾脏特异性生物标志物预测价值
该研究纳入153例成人心脏骤停患者,在自主循环恢复(ROSC)后12小时内采集肾脏特异性生物标志物(NGAL、KIM-1、胱抑素C),评估其与7天内KDIGO III期AKI的关联及预测价值。54例(35%)在7天内发生III期AKI,98例(64%)出院前死亡。发生III期AKI者肌酐、NGAL和胱抑素C中位水平均更高(均p<0.001),KIM-1组间无统计学显著差异。没有任何生物标志物在预测III期AKI、神经功能结局或生存结局方面优于肌酐(均p>0.05),但NGAL、胱抑素C和肌酐预测AKI的能力均优于KIM-1(均p<0.01)。
要点
- 153例成人CA患者中54例(35%)在7天内发生KDIGO III期AKI,98例(64%)出院前死亡。
- 发生III期AKI者肌酐、NGAL、胱抑素C中位水平均高于未发生者(均p<0.001),KIM-1组间无统计学显著差异。
- 没有任何生物标志物在预测III期AKI、神经功能结局或生存结局方面优于肌酐(均p>0.05)。
- NGAL、胱抑素C和肌酐预测AKI的能力均优于KIM-1(均p<0.01)。
适用人群与场景
- 成人心脏骤停患者,且在ROSC后12小时内采集了AKI肾脏特异性生物标志物(NGAL、KIM-1、胱抑素C)。
诊断标准与关键阈值
- AKI诊断采用KDIGO分期,研究终点为入组后7天内发生KDIGO III期AKI。
- 生物标志物采集时间窗为ROSC后12小时内。
研究设计与关键结果
- 研究纳入153例成人CA患者,54例(35%)在7天内发生III期AKI,98例(64%)出院前死亡。
- 发生III期AKI者与未发生者相比,肌酐、NGAL、胱抑素C中位水平均更高(均p<0.001),KIM-1组间无统计学显著差异。
- 没有任何生物标志物在预测III期AKI、神经功能结局或生存结局方面优于肌酐(均p>0.05)。
- NGAL、胱抑素C和肌酐预测AKI的能力均优于KIM-1(均p<0.01)。
证据类型、等级与局限
- 局限:原文未报告局限性。
对床旁实践的改变
- 在心脏骤停ROSC后12小时内,肌酐、NGAL和胱抑素C在后续发生KDIGO III期AKI的患者中更高,但没有任何单一生物标志物在预测AKI、神经功能结局或生存方面优于肌酐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To evaluate the performance of kidney-specific biomarkers (neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and cystatin-C) in early detection of acute kidney injury (AKI) following cardiac arrest (CA) when compared to serum creatinine.
METHODS: Adult CA patients who had kidney-specific biomarkers of AKI collected within 12 h of return of spontaneous circulation (ROSC) were included. The association between renal biomarker levels post-ROSC and the development of KDIGO stage III AKI within 7 days of enrollment were assessed as well as their predictive value of future AKI development, neurological outcomes, and survival to discharge.
RESULTS: Of 153 patients, 54 (35%) developed stage III AKI within 7 days, and 98 (64%) died prior to hospital discharge. Patients who developed stage III AKI, compared to those who did not, had higher median levels of creatinine, NGAL, and cystatin-C (p < 0.001 for all). There was no statistically significant difference in KIM-1 between groups. No biomarker outperformed creatinine in the ability to predict stage III AKI, neurological outcomes, or survival outcomes (p > 0.05 for all). However, NGAL, cystatin-C, and creatinine all performed better than KIM-1 in their ability to predict AKI development (p < 0.01 for all).
CONCLUSION: In post-CA patients, creatinine, NGAL, and cystatin-C (but not KIM-1) measured shortly after ROSC were higher in patients who subsequently developed AKI. No biomarker was statistically superior to creatinine on its own for predicting the development of post-arrest AKI.
参考来源
- Berlin N, Pawar RD, Liu X, et al. Kidney-specific biomarkers for predicting acute kidney injury following cardiac arrest. Resuscitation. 2023. PMID: 37499974. doi:10.1016/j.resuscitation.2023.109911
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。